The role of FDG-PET in the management of oral squamous cell carcinoma (ICD-O-DA M-8070/3)Worldwide, oral and pharyngeal squamous cell carcinoma account for an estimated incidence of about 575 000 tumors and 366 000 tumor deaths every year and, therefore, represent the majority of all head...
Lung adenocarcinoma incidence rates increased, but lung squamous cell carcinoma incidence rates decreased, for both the sexes in recent birth cohorts, particularly in women. In Taiwan, the hotspots of lung adenocarcinoma incidence rates were in the northern, northeastern, and western coastal areas; ...
No previous study has investigated the association between oolong tea consumption and esophageal squamous cell carcinoma (ESCC), we aim to elucidate the association between oolong tea consumption and ESCC and its joint effects with a novel composite index. Methods In a hospital-based case-control stu...
Empty CellICD-O code Squamous cell carcinoma not otherwise specified 8070/3 Keratoacanthoma (synonym: well-differentiated SCC) 8071/3 Acantholytic SCC 8075/3 Spindle cell SCC 8074/3 Verrucous SCC 8051/3 Clear cell SCC 8084/3 Other (uncommon) variants SCC with sarcomatoid differentiationLymphoepi...
ARTICLE Received 16 Sep 2015 | Accepted 18 Jul 2016 | Published 30 Aug 2016 DOI: 10.1038/ncomms12601 OPEN Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates Vida Chitsazzadeh1,2,*, Cristian Coarfa3,*, Jennifer A. Drummond4, ...
Infection or major tissue damage can produce an inflammatory response that is potentially life-threatening; this is known as sepsis. The patient's clinical progression varies considerably, requiring constant monitoring to manage intravenous fluids and vasopressors effectively, alongside other treatment modalit...
ESOPHAGEAL AND GASTRIC CANCER LBA244 Oral Abstract Session Chemotherapy plus camrelizumab versus chemotherapy alone as neoadjuvant treatment for resectable esophageal squamous cell carcinoma (ESCORT-NEO): A multi-center, randomized phase III trial. Yin Li, Jianjun Qin, Liyan Xue, Anlin Hao, Tao ...
skin squamous cell carcinomaBackground:The present study aimed to explore the impact of sulforaphane on the growth of sSCC cells, and the activation of miR-199a-5p Methods:Cell viability, count, apoptosis, and invasion assays were performed in the sSCC cell line (SCC-13) in which miR-199a...
Head and neck squamous cell carcinoma (HNSCC), with 1 000 000 new cases annually, is the sixth most common cancer worldwide.1 Despite the implementation of comprehensive and sequential therapy, a high percentage (50%–60%) of advanced HNSCC patients experience relapse or lymph node/distant meta...
Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC).doi:10.1016/j.oraloncology.2019.05.019Panagiota EconomopoulouGeorge KoutsodontisAreti StratiEfthymios KirodimosEvangelos Giotakis...